Destiny Pharma PLC | WebDisclosure

Basculer en Français

8396	Companies
122097	Keywords
60577	Articles
65553	Press releases

Home
Companies
Destiny Pharma PLC

BRIEF

published on 08/20/2024 at 12:57, 4 months 1 day ago

Destiny Pharma to Present XF-73 Nasal Gel Data at ESCMID Conference

Clinical Data Antibiotic Resistance XF-73 Nasal Gel ESCMID Conference Cardiac Surgery
BRIEF

published on 08/20/2024 at 12:57, 4 months 1 day ago

Destiny Pharma présentera les données du gel nasal XF-73 à la conférence ESCMID

Résistance Aux Antibiotiques Gel Nasal XF-73 Données Cliniques Conférence De L'ESCMID Chirurgie Cardiaque
PRESS RELEASE

published on 08/20/2024 at 12:52, 4 months 1 day ago

Destiny Pharma to Deliver Presentation at the European Society of Clinical Microbiology and Infectious Disease conference on XF-73 Nasal Gel and the Use of Post-Operative Antibiotics in Cardio-vascula
Destiny Pharma to deliver presentation on XF-73 Nasal Gel at ESCMID conference highlighting rapid reduction in S. aureus nasal burden and lower need for post-operative antibiotics

Destiny Pharma XF-73 Nasal Gel ESCMID Conference S. Aureus Post-operative Antibiotics
BRIEF

published on 08/14/2024 at 12:25, 4 months 7 days ago

Destiny Pharma Initiates Research to Explore XF Drug Potential for CF

Biotechnology Cystic Fibrosis MRSA Drug Research XF-73
BRIEF

published on 08/14/2024 at 12:25, 4 months 7 days ago

Destiny Pharma lance des recherches pour explorer le potentiel du médicament XF pour la mucoviscidose

Biotechnologie XF-73 Fibrose Kystique SARM Recherche Sur Les Médicaments
PRESS RELEASE

published on 08/14/2024 at 12:20, 4 months 7 days ago

Destiny Pharma initiates research to explore XF drug potential for CF
Destiny Pharma initiates research to explore XF drug potential for CF. Study focusing on XF-73 to treat MRSA infection in people with cystic fibrosis. Details on the project and potential benefits

Clinical Study Destiny Pharma XF Drug CF Research MRSA Infection
BRIEF

published on 08/13/2024 at 10:41, 4 months 8 days ago

Destiny Pharma plc Shares Now Trading on JP Jenkins

Biotechnology JP Jenkins Share Trading Destiny Pharma Innovative Medicines
BRIEF

published on 08/13/2024 at 10:41, 4 months 8 days ago

Les actions de Destiny Pharma plc sont désormais négociées sur JP Jenkins

Biotechnologie Négociation D'actions Médicaments Innovants Destin Pharma J.P. Jenkins
PRESS RELEASE

published on 08/13/2024 at 10:36, 4 months 8 days ago

Destiny Pharma plc shares now trading on JP Jenkins
Destiny Pharma plc shares now trading on JP Jenkins. Clinical stage biotechnology company focused on preventing & curing infections. Shares admitted to JP Jenkins trading platform

Shares Biotechnology JP Jenkins Trading Platform Destiny Pharma Plc

Accesswire

Published on 12/21/2024 at 01:30, 17 hours 51 minutes ago

Quantum Biopharma Announces Closing of Second Tranche
Published on 12/21/2024 at 01:30, 17 hours 51 minutes ago

iMetal Resources Closes First Tranche of Previously Announced Non-Brokered Private Placement
Published on 12/21/2024 at 00:05, 19 hours 16 minutes ago

Chloeta Awarded GSA OASIS+ IDIQ Contract for Intelligence, Federal Civilian and Defense Support Services
Published on 12/21/2024 at 00:00, 19 hours 21 minutes ago

Amarc Announces Loan Extension
Published on 12/20/2024 at 23:30, 19 hours 51 minutes ago

Boron One Announces Extension to Early Warrant Exercise Incentive Program

View all ACCESSWIRE

EQS Group

Published on 12/21/2024 at 00:51, 18 hours 29 minutes ago

Acquisition of PSI Transcom GmbH by CHAPTERS platform Altamount Software GmbH
Published on 12/21/2024 at 00:45, 18 hours 35 minutes ago

EQS-Adhoc: PSI sells the Mobility business unit
Published on 12/20/2024 at 19:10, 1 day ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 12/20/2024 at 18:56, 1 day ago

CPI PROPERTY GROUP – Progress on Key Initiatives
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

ARYZTA AG Announces New Board Technology Committee

Les Echos

Published on 12/21/2024 at 12:17, 7 hours 3 minutes ago

AXA annonce la signature d’un accord relatif à la vente d'AXA Investment Managers à BNP Paribas
Published on 12/21/2024 at 12:17, 7 hours 3 minutes ago

AXA announces the signing of a share purchase agreement with BNP Paribas relating to the sale of AXA IM
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Kapitaalverhoging door uitoefening van inschrijvingsrechten
Published on 12/20/2024 at 18:00, 1 day 1 hour ago

Capital increase through exercise of subscription rights
Published on 12/20/2024 at 17:55, 1 day 1 hour ago

Déclaration des transactions sur actions propres réalisées du 16/12/2024 au 20/12/2024

View all LES ECHOS COMFI WIRE